Decreased cADPR and increased NAD + in the Cd38 −/− mouse

CD38 is a type II glycoprotein that catalyzes the formation of cyclic ADP-ribose (cADPR), an intracellular calcium signalling molecule, from nicotinamide adenine dinucleotide (NAD +). Using a modified version of the fluorimetric cycling assay for cADPR which reduces between-subject variability, we r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2006-07, Vol.346 (1), p.188-192
Hauptverfasser: Young, Genevieve S., Choleris, Elena, Lund, Frances E., Kirkland, James B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:CD38 is a type II glycoprotein that catalyzes the formation of cyclic ADP-ribose (cADPR), an intracellular calcium signalling molecule, from nicotinamide adenine dinucleotide (NAD +). Using a modified version of the fluorimetric cycling assay for cADPR which reduces between-subject variability, we report significant decreases in brain and lung cADPR, which although similar to previously published values, showed much less individual variation. The reduced variation within each group suggests that the range of cADPR is narrower than previously thought, and that the regulatory mechanisms controlling these levels are more finely tuned. We also report significant increases in brain, lung, and kidney NAD + in the Cd38 −/− mouse, and provide the first experimental demonstration of the proximate relationship between CD38 and NAD +.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2006.05.100